Literature DB >> 22258527

Novel and recurrent non-truncating mutations of the MITF basic domain: genotypic and phenotypic variations in Waardenburg and Tietz syndromes.

Sandy Léger1, Xavier Balguerie, Alice Goldenberg, Valérie Drouin-Garraud, Annick Cabot, Isabelle Amstutz-Montadert, Paul Young, Pascal Joly, Virginie Bodereau, Muriel Holder-Espinasse, Robyn V Jamieson, Amanda Krause, Hongsheng Chen, Clarisse Baumann, Luis Nunes, Hélène Dollfus, Michel Goossens, Véronique Pingault.   

Abstract

The microphthalmia-associated transcription factor (MITF) is a basic helix-loop-helix leucine zipper transcription factor, which regulates melanocyte development and the biosynthetic melanin pathway. A notable relationship has been described between non-truncating mutations of its basic domain and Tietz syndrome, which is characterized by albinoid-like hypopigmentation of the skin and hair, rather than the patchy depigmentation seen in Waardenburg syndrome, and severe hearing loss. Twelve patients with new or recurrent non-truncating mutations of the MITF basic domain from six families were enrolled in this study. We observed a wide range of phenotypes and some unexpected features. All the patients had blue irides and pigmentation abnormalities that ranged from diffuse hypopigmentation to Waardenburg-like patches. In addition, they showed congenital complete hearing loss, diffuse hypopigmentation of the skin, freckling and ocular abnormalities, more frequently than patients with MITF mutations outside the basic domain. In conclusion, the non-truncating mutations of the basic domain do not always lead to Tietz syndrome but rather to a large range of phenotypes. Sun-exposed freckles are interestingly observed more frequently in Asian populations. This variability argues for the possible interaction with modifier loci.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22258527      PMCID: PMC3330215          DOI: 10.1038/ejhg.2011.234

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  27 in total

1.  Apparent digenic inheritance of Waardenburg syndrome type 2 (WS2) and autosomal recessive ocular albinism (AROA).

Authors:  R Morell; R A Spritz; L Ho; J Pierpont; W Guo; T B Friedman; J H Asher
Journal:  Hum Mol Genet       Date:  1997-05       Impact factor: 6.150

2.  Effect of the mutant microphthalmia-associated transcription factor found in Tietz syndrome on the in vitro development of mast cells.

Authors:  Tomonari Shigemura; Masaaki Shiohara; Miyuki Tanaka; Kouichi Takeuchi; Kenichi Koike
Journal:  J Pediatr Hematol Oncol       Date:  2010-08       Impact factor: 1.289

3.  Heterogeneity in Waardenburg's syndrome. Report of a family with ocular albinism.

Authors:  L A Bard
Journal:  Arch Ophthalmol       Date:  1978-07

4.  The melanocortin-1-receptor gene is the major freckle gene.

Authors:  M Bastiaens; J ter Huurne; N Gruis; W Bergman; R Westendorp; B J Vermeer; J N Bouwes Bavinck
Journal:  Hum Mol Genet       Date:  2001-08-01       Impact factor: 6.150

5.  Tietz syndrome (hypopigmentation/deafness) caused by mutation of MITF.

Authors:  S D Smith; P M Kelley; J B Kenyon; D Hoover
Journal:  J Med Genet       Date:  2000-06       Impact factor: 6.318

6.  Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene.

Authors:  M Tassabehji; V E Newton; A P Read
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

7.  Identification of a melanocyte-type promoter of the microphthalmia-associated transcription factor gene.

Authors:  N Fuse; K Yasumoto; H Suzuki; K Takahashi; S Shibahara
Journal:  Biochem Biophys Res Commun       Date:  1996-02-27       Impact factor: 3.575

8.  The mutational spectrum in Waardenburg syndrome.

Authors:  M Tassabehji; V E Newton; X Z Liu; A Brady; D Donnai; M Krajewska-Walasek; V Murday; A Norman; E Obersztyn; W Reardon
Journal:  Hum Mol Genet       Date:  1995-11       Impact factor: 6.150

Review 9.  Insight into the microphthalmia gene.

Authors:  K J Moore
Journal:  Trends Genet       Date:  1995-11       Impact factor: 11.639

10.  Ophthalmological findings in 34 patients with Waardenburg syndrome.

Authors:  J W Delleman; M J Hageman
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1978 Nov-Dec       Impact factor: 1.402

View more
  17 in total

1.  Biallelic Mutations in MITF Cause Coloboma, Osteopetrosis, Microphthalmia, Macrocephaly, Albinism, and Deafness.

Authors:  Aman George; Dina J Zand; Robert B Hufnagel; Ruchi Sharma; Yuri V Sergeev; Janet M Legare; Gregory M Rice; Jessica A Scott Schwoerer; Mariana Rius; Laura Tetri; David M Gamm; Kapil Bharti; Brian P Brooks
Journal:  Am J Hum Genet       Date:  2016-11-23       Impact factor: 11.025

2.  A Novel Pathogenic Variant in the MITF Gene Segregating with a Unique Spectrum of Ocular Findings in an Extended Iranian Waardenburg Syndrome Kindred.

Authors:  Nazanin Jalilian; Mohammad A Tabatabaiefar; Tayyeb Bahrami; Golaleh Karbasi; Mohammad H Bahramian; Abdolrahman Salimpoor; Mohammad R Noori-Daloii
Journal:  Mol Syndromol       Date:  2017-05-30

3.  Late-onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papilloma.

Authors:  Emily W Modlin; Anne M Slavotinek; Thomas N Darling; Stanley Lipkowitz; Frederic G Barr; Pamela N Munster; Leslie G Biesecker; Christopher A Ours
Journal:  Am J Med Genet A       Date:  2022-04-20       Impact factor: 2.578

4.  Subcellular localization and stability of MITF are modulated by the bHLH-Zip domain.

Authors:  Valerie Fock; Sigurdur Runar Gudmundsson; Hilmar Orn Gunnlaugsson; Jon August Stefansson; Vivien Ionasz; Alexander Schepsky; Jade Viarigi; Indridi Einar Reynisson; Vivian Pogenberg; Matthias Wilmanns; Margret Helga Ogmundsdottir; Eirikur Steingrimsson
Journal:  Pigment Cell Melanoma Res       Date:  2018-07-20       Impact factor: 4.693

5.  MITF mutations associated with pigment deficiency syndromes and melanoma have different effects on protein function.

Authors:  Christine Grill; Kristín Bergsteinsdóttir; Margrét H Ogmundsdóttir; Vivian Pogenberg; Alexander Schepsky; Matthias Wilmanns; Veronique Pingault; Eiríkur Steingrímsson
Journal:  Hum Mol Genet       Date:  2013-06-20       Impact factor: 6.150

6.  A Comprehensive Genetic and Clinical Evaluation of Waardenburg Syndrome Type II in a Set of Iranian Patients.

Authors:  Nazanin Jalilian; Mohammad Amin Tabatabaiefar; Mahboubeh Yazdanpanah; Elham Darabi; Tayyeb Bahrami; Ali Zekri; Mohammad Reza Noori-Daloii
Journal:  Int J Mol Cell Med       Date:  2018-03-27

7.  Genome-wide association analysis reveals QTL and candidate mutations involved in white spotting in cattle.

Authors:  Swati Jivanji; Gemma Worth; Thomas J Lopdell; Anna Yeates; Christine Couldrey; Edwardo Reynolds; Kathryn Tiplady; Lorna McNaughton; Thomas J J Johnson; Stephen R Davis; Bevin Harris; Richard Spelman; Russell G Snell; Dorian Garrick; Mathew D Littlejohn
Journal:  Genet Sel Evol       Date:  2019-11-08       Impact factor: 4.297

8.  Expanding the phenotype of E318K (c.952G > A) MITF germline mutation carriers: case series and review of the literature.

Authors:  Leandro Jonata Carvalho Oliveira; Aline Bobato Lara Gongora; Fabiola Ambrosio Silveira Lima; Felipe Sales Nogueira Amorim Canedo; Carla Vanessa Quirino; Janina Pontes Pisani; Maria Isabel Achatz; Benedito Mauro Rossi
Journal:  Hered Cancer Clin Pract       Date:  2021-07-21       Impact factor: 2.857

9.  Otx but not Mitf transcription factors are required for zebrafish retinal pigment epithelium development.

Authors:  Brandon M Lane; James A Lister
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

10.  Rapid Discovery of De Novo Deleterious Mutations in Cattle Enhances the Value of Livestock as Model Species.

Authors:  E Bourneuf; P Otz; H Pausch; V Jagannathan; P Michot; C Grohs; G Piton; S Ammermüller; M-C Deloche; S Fritz; H Leclerc; C Péchoux; A Boukadiri; C Hozé; R Saintilan; F Créchet; M Mosca; D Segelke; F Guillaume; S Bouet; A Baur; A Vasilescu; L Genestout; A Thomas; A Allais-Bonnet; D Rocha; M-A Colle; C Klopp; D Esquerré; C Wurmser; K Flisikowski; H Schwarzenbacher; J Burgstaller; M Brügmann; E Dietschi; N Rudolph; M Freick; S Barbey; G Fayolle; C Danchin-Burge; L Schibler; B Bed'Hom; B J Hayes; H D Daetwyler; R Fries; D Boichard; D Pin; C Drögemüller; A Capitan
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.